Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gollob
David S. Gollob, Simsbury, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090304943 | Method for Forming Ceramic Containing Composite Structure - A method for forming a ceramic containing composite structure is proposed comprising the steps of (a) feeding a ceramic component that sublimes and a metallic or semi-conductor material that does not sublime into a thermal spray apparatus, (b) spraying the ceramic component and the metallic or semi-conductor material onto a substrate, whereby the ceramic component and the metallic or semi-conductor material deposit on the surface of the substrate, and (c) keeping the metallic or semi-conductor material on the substrate surface plastic during spraying at least in the region where the metallic or semi-conductor material actually strikes the surface. | 12-10-2009 |
Jared Gollob, Boston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100168206 | GNAQ Targeted dsRNA Compositions And Methods For Inhibiting Expression - The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a G-alpha q subunit (GNAQ) of a heterotrimeric G gene, and methods of using the dsRNA to inhibit expression of GNAQ. | 07-01-2010 |
Michael H. Gollob, Ottawa CA
| Patent application number | Description | Published |
|---|---|---|
| 20090054248 | CONNEXIN 40 TISSUE SPECIFIC GENE MUTATIONS - A method of detecting cardiac arrhythmia in a patient is described. This method involves determining whether there is a mutation in the nucleotide sequence, the amino acid sequence, or both, of connexin40 obtained from a patient. The mutation may be localized within the transmembrane domain of connexin40. Furthermore, there is described a method of identifying a compound for the treatment of cardiac arrhythmia. This method involves providing a cell culture that is characterized by having impaired intracellular trafficking, impaired electrical coupling, reduced gap junction plaque formation, reduced intracellular coupling, or a combination thereof, when compared to a wild-type cell. A compound is added to the cell culture, and restoration of intracellular trafficking, electrical coupling, gap junction plaque formation, intracellular coupling, or a combination thereof, is monitored. | 02-26-2009 |
Peter Gollob, Graz AT
| Patent application number | Description | Published |
|---|---|---|
| 20110267005 | Active Charge Balancing Circuit - A charge balancing circuit and an energy storage arrangement with a charge balancing circuit are disclosed. | 11-03-2011 |